ATE521364T1 - Zusammensetzung und verfahren zur erhöhung der zelldichte in zellkulturen, die mit dem lentivirus infiziert sind - Google Patents

Zusammensetzung und verfahren zur erhöhung der zelldichte in zellkulturen, die mit dem lentivirus infiziert sind

Info

Publication number
ATE521364T1
ATE521364T1 AT02769679T AT02769679T ATE521364T1 AT E521364 T1 ATE521364 T1 AT E521364T1 AT 02769679 T AT02769679 T AT 02769679T AT 02769679 T AT02769679 T AT 02769679T AT E521364 T1 ATE521364 T1 AT E521364T1
Authority
AT
Austria
Prior art keywords
composition
lentivirus
cultures infected
cell cultures
cell density
Prior art date
Application number
AT02769679T
Other languages
English (en)
Inventor
Anne Christine Thomas
Terry Ng
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Application granted granted Critical
Publication of ATE521364T1 publication Critical patent/ATE521364T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
AT02769679T 2001-05-10 2002-05-03 Zusammensetzung und verfahren zur erhöhung der zelldichte in zellkulturen, die mit dem lentivirus infiziert sind ATE521364T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29009601P 2001-05-10 2001-05-10
PCT/US2002/014271 WO2002091994A2 (en) 2001-05-10 2002-05-03 Composition and method for increasing cell density in cell cultures infected with lentivirus

Publications (1)

Publication Number Publication Date
ATE521364T1 true ATE521364T1 (de) 2011-09-15

Family

ID=23114512

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02769679T ATE521364T1 (de) 2001-05-10 2002-05-03 Zusammensetzung und verfahren zur erhöhung der zelldichte in zellkulturen, die mit dem lentivirus infiziert sind

Country Status (25)

Country Link
US (1) US7160721B2 (de)
EP (2) EP2298343A1 (de)
JP (1) JP4283544B2 (de)
KR (1) KR20040029981A (de)
CN (1) CN1326992C (de)
AT (1) ATE521364T1 (de)
AU (1) AU2002342568B2 (de)
BG (1) BG108315A (de)
BR (1) BR0209482A (de)
CA (1) CA2446131C (de)
CY (1) CY1112123T1 (de)
CZ (1) CZ20033046A3 (de)
DK (1) DK1385540T3 (de)
ES (1) ES2369846T3 (de)
HR (1) HRP20030974A2 (de)
HU (1) HUP0400283A2 (de)
MX (1) MXPA03010208A (de)
NO (1) NO20034961L (de)
NZ (1) NZ529326A (de)
PL (1) PL373847A1 (de)
PT (1) PT1385540E (de)
SI (1) SI1385540T1 (de)
WO (1) WO2002091994A2 (de)
YU (1) YU88703A (de)
ZA (1) ZA200309556B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10920483B2 (en) 2018-10-25 2021-02-16 Mark Mutchnik Window seal for preventing water penetration

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215107A (en) * 1978-12-29 1980-07-29 Merck & Co., Inc. Parainfluenza virus vaccine and its preparation
JPS57194787A (en) * 1981-05-28 1982-11-30 Ajinomoto Co Inc Culture medium for animal cell
US6107077A (en) * 1987-08-26 2000-08-22 Yamamoto; Janet K. Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
JPH05509306A (ja) * 1990-07-30 1993-12-22 ジ・アップジョン・カンパニー ヒト・レトロウイルスの抑制およびエイズの治療のためのヘキサ―Ｎ―（ｏ―ヒドロキシベンジル）ネオマイシンＢ
JPH08502966A (ja) * 1992-10-23 1996-04-02 ユニバーシティー・オブ・マサチューセッツ・メディカル・センター Ｒｎａ／リガンド結合の低分子抑制
US5534408A (en) * 1993-09-24 1996-07-09 University Of Massachusetts Medical Center 2-deoxystreptamine aminoglycoside inhibition of HIV RRE/Rev binding
AU711350B2 (en) 1994-05-10 1999-10-14 Zoetis Services Llc Improved modified live BRSV vaccine
IL163873A0 (en) 1995-08-25 2005-12-18 Univ Florida Il-2 independent feline derived T cell

Also Published As

Publication number Publication date
JP2005508139A (ja) 2005-03-31
PL373847A1 (en) 2005-09-19
US20020197714A1 (en) 2002-12-26
NO20034961L (no) 2003-12-01
EP2298343A1 (de) 2011-03-23
NO20034961D0 (no) 2003-11-07
SI1385540T1 (sl) 2011-10-28
US7160721B2 (en) 2007-01-09
CA2446131C (en) 2013-07-02
WO2002091994A3 (en) 2003-05-08
EP1385540A2 (de) 2004-02-04
EP1385540B1 (de) 2011-08-24
KR20040029981A (ko) 2004-04-08
BG108315A (bg) 2005-03-31
HUP0400283A2 (en) 2007-08-28
CZ20033046A3 (en) 2004-03-17
CN1514734A (zh) 2004-07-21
JP4283544B2 (ja) 2009-06-24
DK1385540T3 (da) 2011-10-24
YU88703A (sh) 2006-05-25
WO2002091994A2 (en) 2002-11-21
ES2369846T3 (es) 2011-12-07
CN1326992C (zh) 2007-07-18
AU2002342568B2 (en) 2007-11-01
PT1385540E (pt) 2011-10-21
NZ529326A (en) 2006-09-29
HRP20030974A2 (en) 2004-02-29
EP1385540A4 (de) 2004-12-01
BR0209482A (pt) 2007-01-02
ZA200309556B (en) 2005-02-23
CY1112123T1 (el) 2015-11-04
MXPA03010208A (es) 2004-03-10
CA2446131A1 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
AU2002212275A1 (en) Bio-reactor for the cultivation of micro-organisms and method for the production thereof
HK1019233A1 (en) Animal cells and processes for the replication of influenza viruses
CY1108329T1 (el) Κυτταρικη καλλιεργεια
ATE334188T1 (de) Zellkulturspinnerflaschen
NO20006096L (no) Medium for dyrking av dyreceller og fremgangsmåte for fremstilling av protein ved anvendelse av de samme
TW200506058A (en) Method for culturing organic blue-green algae
EP1687413A4 (de) Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle enthaltende pharmazeutische zusammensetzung gegen eine neurodegenerative krankheit
ES2136099T3 (es) Induccion de celulas callosas y preparacion de taxanos.
ATE521364T1 (de) Zusammensetzung und verfahren zur erhöhung der zelldichte in zellkulturen, die mit dem lentivirus infiziert sind
AU2003206926A1 (en) Cultivation method for micro-organisms and bioreactor
DE60136558D1 (de) Verfahren zur kultivierung humaner chondrozyten
WO1996007730A3 (de) Chemisches verfahren zur förderung der proliferation von tierischen zellen
DE69520098D1 (de) Methode zur kontrolle der metallophosphatpraezipitation in fermentationen mit hoher zelldichte
ATE230434T1 (de) Vorrichtung zum kultivieren von mikroorganismen
HK1045715A1 (en) Method of cell cultivation.
WO2002064811A3 (fr) Procede pour produire des proteines recombinantes, marquees par au moins un isotope
FR2801900B1 (fr) Methode de production de cellules animales adherentes
ATE290067T1 (de) Verfahren zur erhöhung der wachstumsrate von zellen in statischen flüssigmedien
AU6262786A (en) Growing aids virus in cell lines lacking human class ii histocompatability antigens
ATE204508T1 (de) Mikrobiologisches verfahren zur beseitigung von halogenierten ethenen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1385540

Country of ref document: EP